Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 4, 2008, Pages 412-414

  Ragino, Yu I ^a   Baum, V A ^a   Polonskaya, Ya V ^a   Sadovski, E V ^a   Baum, S R ^a   Nikitin, Yu P ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Endothelial dysfunction; Hemostasis disturbances; Myocardial infarction; Oxidized fibrinogen; Oxidized lipids and proteins

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; NITRIC OXIDE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; LEUKOCYTE AGGREGATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ADULT; AGED; BLOOD COAGULATION DISORDERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FIBRINOGEN; HEMOSTASIS; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATION-REDUCTION; VASCULAR DISEASES;

EID: 55649092022     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0104-8     Document Type: Article

References (14)

1. A. V. Aseichev, O. A. Azizova, and B. A. Zhambalova, Byull. Eksp. Biol. Med., 133, No. 1, 51-54 (2002).
2. Z. S. Barkagan and A. P. Momot, Diagnostics and Controlled Therapy of Hemostasis Disorders [in Russian], Moscow (2001).
3. P. P. Golikov and N. Yu. Nikolaeva, Biomed. Khim., 50, No. 1, 79-85 (2004).
4. A. A. Gromov, A. V. Rabko, M. V. Kruchinina, and V. A. Baum, Vestn. Novosib. Gos. Univer., 4, No. 2, 31-38 (2006).
5. E. E. Dubinina, S. O. Bupmistrov, D. A. Khodov, and G. E. Porotov, Vopr. Med. Khimii, 41, No. 1, 24-26 (1995).
6. V. Z. Lankin, A. K. Tikhadze, and Yu. N. Belenkov, Kardiologiya, No. 7, 48-62 (2000).
7. Yu. I. Ragino, V. A. Baum, Ya. V. Polonskaya, and A. A. Gromov, Klin. Lab. Diagn., No. 1, 13-16 (2007).
8. E. V. Roitman, O. A. Azizova, Yu. A. Morozov, and A. V. Aseichev, Byull. Eksp. Biol. Med., 138, No. 9, 277-279 (2004).
9. M. Belisario, D. Di, A. Pelagalli, et al., Biochimie, 79, No. 7, 449-455 (1997).
10. G. R. De Meyer, M. Hoylaerts, M. M. Kockx, et al., Arterioscler. Thromb. Vasc. Biol., 19, No. 10, 2524-2534 (1999).
11. E. Ernst and K. L. Resch, Ann. Intern. Med., 118, No. 12, 956-963 (1993).
12. H. Koukkunen, K. Penttila, A. Kemppainen, et al. Ann. Med., 33, No. 1, 37-47 (2001).
13. E. R. Stadtman and R. L. Levine, Ann. N. Y. Acad. Sci., 899, 191-208 (2000).
14. R. Stocker and J. F. Keaney, Jr., Physiol. Rev., 84, No. 4, 1381-1478 (2004).